Markets
Stocks
Mutual Funds & ETF's
Sectors
Investing Tools
Overview
Market News
Analysts
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
Local Stocks
BIOMARIN PHARM (NQ: BMRN)
+0.00 (0.00%)
at
19.17
2,043,457 in Volume
Add to:
My Watchlist
Data as of 04:30 PM EST Feb 9,2010
Quote
Overview
Price and Volume
View Detailed Quote
chart
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
Today's Open 19.74
Bid (Size) 19.17 (400)
Ask (Size) 19.18 (4800)
Prev. Close 19.17
Today's Range 18.97 - 20.24
52wk Range 9.930 - 21.50
Shares Outstanding 100,729,518
Morningstar Profile
View Full Profile
BIOMARIN PHARM
The Company develops and commercializes biopharmaceuticals for serious diseases and medical conditions.
Healthcare
Biotechnology
Exchange Traded NQ
Market Cap 1.93B
Related Companies REGN OSIP ONXX INRLF
Top News
Read More
Drug stocks gain; Cell Therapeutics rebounds   
10:23 EST
Drug stocks gain in early action while shares of Cell Therapeutics bounced back after diving almost 25% on Monday over concerns about its new non-Hodgkin's lymphoma treatment pixantrone. Read More
category Earnings , AZN , Market News , and 11 more.
from MarketWatch
On The Fly: Analysts Upgrade Summary   
9:00 EST
See the rest of the story here . Theflyonthewall.com is Wall Street's specialist in breaking equity news. Veteran traders build a proprietary feed of news that's faster and more relevant than any other... Read More
category General news
from theflyonthewall.com
More News
Read More
Upgrades & Downgrades: Monsanto in the Money   
8:45 EST
category News and Views
from Minyanville
Rodman Reports Record 2009 Financial Results
8:00 EST
from Business Wire News Releases
Roth Capital Upgrades BioMarin Pharmaceutical (BMRN) to Buy   
7:26 EST
from StreetInsider.com News Articles
BioMarin upgraded to Buy from Hold at Roth Capital   
6:27 EST
category Rec/Upgrade
from theflyonthewall.com
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Conference calls info supplied by OpenCompany
Fundamental data supplied by Morningstar
Stock quotes supplied by Telekurs USA
© Copyright FinancialContent, Inc.